Valbenazine for obsessive-compulsive disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called valbenazine can help reduce symptoms of moderate to severe OCD in adults. If you have OCD and are not currently changing your treatment, you may be able to join and see if this new approach works for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with obsessive-compulsive disorder (OCD) by a doctor
- Your OCD symptoms are at least moderate or severe (scored 21 or higher on a standard OCD scale)
- You are not currently pregnant, breastfeeding, or planning pregnancy without effective birth control
- You do not have an unstable medical condition, a history of bipolar disorder or psychosis, or a recent alcohol or drug problem
- You have not started a new type of therapy or changed your OCD medication in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.
This trial tests if a gentle brain stimulation technique called tDCS can help people with severe, long-lasting obsessive-compulsive disorder that hasn't improved with other treatments. It aims to see if symptoms can be triggered and then reduced.
This trial tests whether a gentle brain stimulation (tDCS) combined with facing your fears can help people with hard-to-treat OCD. If you've tried multiple treatments without relief, this study may offer a new option.
This study tests a personalized brain-stimulation approach to help people with obsessive-compulsive disorder (OCD) focused on contamination worries. If you have the “contamination” type of OCD and meet the safety and medication rules, you may be able to join and see whether this targeted treatment reduces symptoms.
This study looks at whether deep brain stimulation (DBS) helps people with long-term, treatment-resistant obsessive-compulsive disorder (OCD), and how it affects quality of life. It involves careful screening because it’s meant for OCD that has not responded to several medication and therapy attempts.
This trial tests whether MDMA plus cognitive behavioral therapy (CBT) can reduce OCD symptoms in adults who have tried standard OCD treatments before. You may be asked to pause certain medicines and follow specific diet/medication rules around the study session.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.